Descriptive analysis of endoscopic findings in patients with a family history of colorectal cancer.

BACKGROUND: The presence of a family history implies an increased risk for developing colorectal cancer (CRC), and may require a different screening strategy. The aim of this study was to evaluate lesions found during colonoscopies of patients that had a family history of CRC. MATERIAL AND METHODS: A retrospective study was conducted that included consecutive colonoscopies performed on patients with a family history of CRC at a referral center within the period from April 2000 to January 2012. The colonoscopic findings were analyzed in relation to sex, age, and the presence or absence of symptoms. RESULTS: Data from 3,792 colonoscopies were collected. The mean age of the patients was 53.14 years (SD 12.22), and 57.4% were women. Colonoscopy was normal in 71.7% of the cases, with hyperplastic polyps being detected in 7.1%, and adenomatous polyps in 19.8% (39.4% of them were high risk). There was a 1.5% presence of adenocarcinomas in the subjects. Polyps and CRC were predominant in men (P=.001 and P=.027, respectively) and there was a linear increase with age. Symptomatic patients had a higher CRC detection rate (P<.001), but no differences were observed in relation to polyp diagnosis. CONCLUSIONS: Age and male sex increased the risk for presenting with CRC or adenomas in the group of patients with a family history of CRC, and the presence of symptoms was associated with a greater risk for presenting with CRC.

Inflammatory status is different in relationship to insulin resistance in severely obese people and changes after bariatric surgery or diet-induced weight loss.

AIM: To assess if insulin resistance is related to a different inflammatory status (especially lymphocyte subpopulations) in severely obese people and to evaluate changes after weight loss either following a very-low calorie diet (VLCD) or bariatric surgery. RESEARCH METHODS & PROCEDURES: Severely obese patients were consecutively recruited in our Obesity Unit. Blood lymphocyte subpopulations and inflammatory parameters were measured baseline, after a VLCD during 6 weeks and one year after biliopancreatic diversion. Insulin resistance was evaluated by Homeostasis Model Assessment (HOMA) index. RESULTS: After excluding diabetic patients, 58 patients were studied. HOMA index classified 63.8% of them as insulin resistant (IR). Serum baseline levels of inflammatory cytokines were not significantly different between IR and insulinsensitive (IS) patients but, regarding lymphocyte subpopulations, Natural Killer (NK) cells were higher in IR patients [(305.0 (136.7) vs. 235.0 (80.7) cells/µL, p=0.047]. NK cells showed a significant positive correlation with HOMA index (r=0.484, p=0.000) and with the carbohydrate content of the diet (r=0.420, p=0.001). After VLCD, NK cells significantly decreased, but only in IR patients and in those losing more than 10% of their initial weight. After biliopancreatic diversion, total and CD8 T Lymphocytes, B lymphocytes and NK cells also decreased but only in IR individuals. CONCLUSION: NK cells are significantly increased in IR severely obese people in respect to IS, suggesting a slightly different immune status in these patients with a probable dietary relationship. Weight loss could reverse this increase either after VLCD or after bariatric surgery.

[Effects of preoperative weight loss with a very low calorie diet (VLCD) on weight loss after biliopancreatic diversion in patients with severe obesity]. / Efectos de la pérdida de peso mediante una dieta muy baja en calorías (VLCD) sobre la pérdida de peso tras derivación biliopancreática en pacientes con obesidad severa.

BACKGROUND: Weight loss before bariatric surgery, achieved by means of a very low calorie diet (VLCD) has been recently reported to be related to a lower rate of postoperative complications. However, it is controversial if preoperative weight loss after VLCD could improve postoperative weight loss. AIMS: To assess the effectiveness of a preoperative VLCD for 6 weeks in weight loss one year after bariatric surgery. To evaluate the changes obtained in anthropometric measures and biochemical parameters after VLCD. METHODS: Prospective uncontrolled study including severely obese patients undergoing biliopancreatic diversion in our Obesity Unit in 2008-2010. Patients included followed a VLCD providing 840 kcal and 60 g of protein (Optisource®). Descriptive data are presented as mean (standard deviation) and after checking a normal distribution is followed, they were analyzed by Student s T test, ANOVA or Pearson correlation. RESULTS: We evaluated 107 obese patients, 43.5 (10.2) years-old, 72% women, with initial weight 122.4 (18.6) Kg and BMI 46.8 (5.5) kg/m(2). 24.5% of them lost more than 10 % of initial weight and 73.5% more than 5% after following VLCD. Mean percentage of excess weight loss (% PSP) one year after surgery was 59.6 (13.4)%, and although it was higher for those patients losing more weight after VLCD, a significant correlation was not found: those who lost more than 5% showed %PSP 59.5 (13.8) % after twelve months and 68.4 (16.2) % of percentage of excess BMI loss (%PEIMC), vs 57,9 (13,1) % and 68.5 (16.6) % if they didn t lose that amount of weight. Those patients losing more than 10% achieved %PSP 63.3 (13.7) and %PEIMC 70.9 (14.7) vs 58.2 (14.0) y 67.7 (16.7) vs those not losing that amount. Significant correlations between preoperative loss with VLCD and %PSP or %PEIMC at 3,6,9 and 12 months were not found, and only %PSP 1 month after surgery correlated with %PSP after VLCD (r = 0.454, p = 0.003). CONCLUSIONS: Preoperative weight loss with VLCD in severely obese patients did not show to improve either %PSP or %PEIMC one year after bariatric surgery.

Introducción: Se ha comunicado recientemente que la reducción de peso previa a cirugía bariátrica mediante dieta muy baja en calorías (VLCD) durante 2 semanas supone menor tasa de complicaciones postoperatorias. Es debatido, sin embargo, si la pérdida de peso preoperatoria con VLCD puede favorecer pérdida de peso postoperatoria. Objetivos: Valorar la eficacia de una VLCD, seguida durante 6 semanas preoperatorias, en el descenso de peso conseguido al 2013 de la cirugía bariátrica. Evaluar los cambios en parámetros antropométricos y bioquímicos conseguidos con dicha dieta. Metodología: Estudio prospectivo no controlado en los pacientes obesos sometidos a derivación biliopancréatica en la Unidad de Obesidad de referencia en el periodo 2008-2010. Los pacientes recibieron durante 6 semanas previas a la intervención una VLCD que aportaba diariamente 840 kcal y 60 g de proteínas (Optisource®). Los datos descriptivos se presentan como media y desviación estándar (DS), y tras comprobar su distribución normal, fueron analizados mediante prueba t de Student, ANOVA o correlación de Pearson. Resultados: Fueron valorados 107 pacientes obesos, de 43,5 (10,2) 2013s, el 72 % fueron mujeres con peso inicial 122,4 (18,6) Kg e IMC de 46,8 (5,5) kg/m2. Un 24,5% perdieron más de 10 % de su peso inicial y un 73,5% más de 5% tras VLCD. La media de porcentaje pérdida de exceso de peso (% PSP) a los 12 meses de la intervención fue 59,6 (13,4)%, y aunque fue mayor en los pacientes que habían perdido peso con VLCD, no se asoció de forma significativa: aquellos pacientes con pérdida mayor de 5% perdieron a los 12 meses 59,5 (13,8)% de PSP y 68,4 (16,2) % de exceso de IMC (%PEIMC), frente a 57,9 (13,1) % y 68,5 (16,6) % si no conseguían esa pérdida. El grupo de pacientes con pérdida mayor de 10 % consiguió %PSP de 63,3 (13,7) y %PEIMC de 70,9 (14,7) vs 58,2 (14,0) y 67,7 (16,7) si no perdieron >10% del peso inicial. No se encontró correlación entre la pérdida preoperatoria con VLCD y %PSP ni de exceso de IMC (%PEIMC) a 3,6,9 y 12 meses, sólo el %PSP a 1 mes se correlacionó con %PSP con VLCD (r = 0,454, p = 0,003). Conclusiones: La pérdida de peso preoperatoria mediante VLCD en pacientes obesos mórbidos no hademostrado favorecer la pérdida de exceso de peso ni de exceso de IMC al 2013 de la cirugía bariátrica.

Efectos de la pérdida de peso mediante una dieta muy baja en calorías (VLCD) sobre la pérdida de peso tras derivación biliopancreática en pacientes con obesidad severa / Effects of preoperative weight loss with a very low calorie diet (VLCD) on weight loss after biliopancreatic diversion in patients with severe obesity

Introducción: Se ha comunicado recientemente que la reducción de peso previa a cirugía bariátrica mediante dieta muy baja en calorías (VLCD) durante 2 semanas supone menor tasa de complicaciones postoperatorias. Es debatido, sin embargo, si la pérdida de peso preoperatoria con VLCD puede favorecer pérdida de peso postoperatoria. 
Objetivos: Valorar la eficacia de una VLCD, seguida durante 6 semanas preoperatorias, en el descenso de peso conseguido al año de la cirugía bariátrica. Evaluar los cambios en parámetros antropométricos y bioquímicos conseguidos con dicha dieta. Metodología: Estudio prospectivo no controlado en los pacientes obesos sometidos a derivación biliopancréatica en la Unidad de Obesidad de referencia en el periodo 2008-2010. Los pacientes recibieron durante 6 semanas previas a la intervención una VLCD que aportaba diariamente 840 kcal y 60 g de proteínas (Optisource®). Los datos descriptivos se presentan como media y desviación estándar (DS), y tras comprobar su distribución normal, fueron analizados mediante prueba t de Student, ANOVA o correlación de Pearson. Resultados: Fueron valorados 107 pacientes obesos, de 43,5 (10,2) años, el 72 % fueron mujeres con peso inicial 122,4 (18,6) Kg e IMC de 46,8 (5,5) kg/m2. Un 24,5% perdieron más de 10 % de su peso inicial y un 73,5% más de 5% tras VLCD. La media de porcentaje pérdida de exceso de peso (% PSP) a los 12 meses de la intervención fue 59,6 (13,4)%, y aunque fue mayor en los pacientes que habían perdido peso con VLCD, no se asoció de forma significativa: aquellos pacientes con pérdida mayor de 5% perdieron a los 12 meses 59,5 (13,8)% de PSP y 68,4 and 71 (16,2) % de exceso de IMC (%PEIMC), frente a 57,9 (13,1) % y 68,5 (16,6) % si no conseguían esa pérdida. El grupo de pacientes con pérdida mayor de 10 % consiguió %PSP de 63,3 (13,7) y %PEIMC de 70,9 (14,7) vs 58,2 (14,0) y 67,7 (16,7) si no perdieron >10% del peso inicial. No se encontró correlación entre la pérdida preoperatoria con VLCD y %PSP ni de exceso de IMC (%PEIMC) a 3,6,9 y 12 meses, sólo el %PSP a 1 mes se correlacionó con %PSP con VLCD (r = 0,454, p = 0,003). Conclusiones: La pérdida de peso preoperatoria mediante VLCD en pacientes obesos mórbidos no ha demostrado favorecer la pérdida de exceso de peso ni de exceso de IMC al año de la cirugía bariátrica (AU)

Background: Weight loss before bariatric surgery, achieved by means of a very low calorie diet (VLCD) has been recently reported to be related to a lower rate of postoperative complications. However, it is controversial if preoperative weight loss after VLCD could improve postoperative weight loss. Aims: To assess the effectiveness of a preoperative VLCD for 6 weeks in weight loss one year after bariatric surgery. To evaluate the changes obtained in anthropometric measures and biochemical parameters after VLCD. Methods: Prospective uncontrolled study including severely obese patients undergoing biliopancreatic diversión in our Obesity Unit in 2008-2010. Patients included followed a VLCD providing 840 kcal and 60 g of protein (Optisource®). Descriptive data are presented as mean (standard deviation) and after checking a normal distribution is followed, they were analyzed by Student s T test, ANOVA or Pearson correlation. Results: We evaluted 107 obese patients, 43.5 (10.2) years-old, 72% women, with initial weight 122.4 (18.6) Kg and BMI 46.8 (5.5) kg/m2. 24.5% of them lost more than 10 % of initial weight and 73.5% more than 5% after following VLCD. Mean percentage of excess weight loss (% PSP) one year after surgery was 59.6 (13.4)%, and although it was higher for those patients losing more weight after VLCD, a significant correlation was not found: those who lost more than 5% showed %PSP 59.5 (13.8) % after twelve months and 68.4 (16.2) % of percentage of excess BMI loss (%PEIMC), vs 57,9 (13,1) % and 68.5 (16.6) % if they didn’t lose that amount of weight. Those patients losing more than 10% achieved %PSP 63.3 (13.7) and %PEIMC 70.9 (14.7) vs 58.2 (14.0) y 67.7 (16.7) vs those not losing that amount. Significant correlations between preoperative loss with VLCD and %PSP or %PEIMC at 3,6,9 and 12 months were not found, only %PSP 1 month after surgery correlated with %PSP after VLCD (r = 0.454, p = 0.003). Conclusions: Preoperative weight loss with VLCD in severely obese patients did not show to improve either %PSP or %PEIMC one year after bariatric surgery (AU)

Comparison of different body composition mesurements in severely obese patients in the clinical setting / Comparación de las diferentes medidas de la composición corporal en pacientes con obesidad grave en un contexto clínico

Background Aims: Body composition measurements seem to be not reliable enough in obese patients. Our aim was to compare single frequency-bioelectrical impedance (SF-BIA) analysis; foot-to-foot impedance meters (FFI) or upper body fat analysers (UBFA) and DXA (Dual-energy X-ray absorptiometry) in severely obese patients. Patients and methods: Cross-sectional study including 40 severely obese patients. Bioelectrical impedance was performed for SF-BIA (Holtain (H) and OMRON BF 500 (O500)), FFI (Tanita TBF-300 (T)) and UBFA (Omron BF 300 (O300)). DXA scans were performed using a Lunar iDXA. The data were analysed using Pearson's correlation and Bland Altman plots were also drawn to evaluate any agreements. Results: The percentage and total body fat values were 49.2% and 55.2 kg measured with DXA, 44.3%/53.4 kg with O300, 50.6%/58.3 kg with O500, 45.4%/55.4 kg with H and 49.1%/60.3 kg with T. The Holtain BIA showed the worst correlation with DXA for both %BF and FFM. Although the measurements of % body fat, fat mass and fat-free mass were significantly correlated with DXA, each method showed wide limits of agreement, although T was most closely correlated with DXA. Conclusion: Compared to DXA, FFI and UBFA could be useful for assessing body composition in severely obese people, although they appeared to underestimate %BF and FM and their limits of agreement were too wide (AU)

Introducción: La medida de la composición corporal parece no tener suficiente fiabilidad en los pacientes obesos. Nuestro objetivo fue comparar técnicas de impedancia monofrecuencia (SF-BIA), impedanciómetros de arco inferior (FFI) o de arco superior (UBFA) con densitometría (DXA) en pacientes con obesidad severa. Pacientes y métodos: Estudio transversal de 40 pacientes con obesidad severa. Se realizó medida de composición corporal mediante impedancia bioeléctrica realizada con dos instrumentos de medida de impedancia monofrecuencia (Holtain (H) y OMRON BF 500 (O500)), FFI (Tanita TBF-300 (T)) y UBFA (Omron BF 300 (O300)). La densitometría para composición corporal se llevó a cabo en un DXA Lunar iDXA. Se analizaron los datos mediante correlación de Pearson y se empleó el método de Bland Altman para evaluar los acuerdos entre técnicas. Resultados: Los valores absolutos y porcentajes grasa corporal fueron 49,2% y 55,2 kg medidos con DXA, 44,3%/53,4 kg con O300, 50,6%/58,3 kg con O500, 45,4%/55,4 kg con H y 49,1%/60,3 kg con T. El impedanciómetro tipo Holtain mostró la peor correlación con DXA, tanto para Porcentaje de grasa como masa libre de grasa. Aunque las medidas de porcentaje de grasa, masa grasa total y masa libre de grasa se correlacionaron con DXA de forma significativa, los límites de concordancia de cada método fueron demasiado amplios. T fue el método mejor correlacionado con DXA. Conclusión: En comparación con DXA, FFI y UBFA podrían ser útiles para valorar composición corporal en pacientes obesos severos, aunque teniendo en cuenta que parecen infraestimar %BF y FM y que sus límites de concordancia son bastante amplios (AU)

Comparison of different body composition measurements in severely obese patients in the clinical setting.

BACKGROUND AIMS: Body composition measurements seem to be not reliable enough in obese patients. Our aim was to compare single frequency-bioelectrical impedance (SF-BIA) analysis; foot-to-foot impedance meters (FFI) or upper body fat analysers (UBFA) and DXA (Dual-energy X-ray absorptiometry) in severely obese patients. PATIENTS AND METHODS: Cross-sectional study including 40 severely obese patients. Bioelectrical impedance was performed for SF-BIA (Holtain (H) and OMRON BF 500 (O500)), FFI (Tanita TBF-300 (T)) and UBFA (Omron BF 300 (O300)). DXA scans were performed using a Lunar iDXA. The data were analysed using Pearson's correlation and Bland Altman plots were also drawn to evaluate any agreements. RESULTS: The percentage and total body fat values were 49.2% and 55.2 kg measured with DXA, 44.3%/53.4 kg with O300, 50.6%/58.3 kg with O500, 45.4%/55.4 kg with H and 49.1%/60.3 kg with T. The Holtain BIA showed the worst correlation with DXA for both %BF and FFM. Although the measurements of % body fat, fat mass and fat-free mass were significantly correlated with DXA, each method showed wide limits of agreement, although T was most closely correlated with DXA. CONCLUSION: Compared to DXA, FFI and UBFA could be useful for assessing body composition in severely obese people, although they appeared to underestimate %BF and FM and their limits of agreement were too wide.

Utilidad de un índice de puntuación como predictor de fibrosis hepática en pacientes obesos sometidos a cirugía bariátrica / Usefulness of an index score as a predictor of hepatic fibrosis in obese patients undergoing bariatric surgery

Objetivo: evaluar la utilidad de un índice de puntuación clínicano invasivo para predecir fibrosis hepática en la esteatosis asociadaa la obesidad mórbida.Pacientes y métodos: se incluyeron 88 pacientes, intervenidosde cirugía bariátrica en el área sanitaria de León, que presentaronen la biopsia hepática una esteatosis mayor del 5%. Se tratade un estudio retrospectivo en el que se calculó el índice de fibrosisa partir de los datos analíticos del preoperatorio, y se comparósu resultado con los datos de la biopsia hepática intraoperatoriarealizada. Para el análisis los pacientes fueron agrupados segúnpresentaban en la biopsia hepática fibrosis avanzada (grado 3-4) ono (grado 0-2). El punto de corte usado para diagnosticar fibrosisavanzada fue 0,676 (punto de corte alto), y el punto de corte paraexcluir fibrosis avanzada fue -1,455 (punto de corte bajo).Resultados: la prevalencia de fibrosis avanzada en las muestrashistológicas fue del 5,5% y el 65,9% de los pacientes no presentabanfibrosis. Para el punto de corte bajo el valor predictivonegativo fue del 100% y la sensibilidad del 100%. Para el puntode corte alto el valor predictivo positivo fue del 1,7% y la especificidaddel 31,3%.Conclusiones: el sistema de puntuación analizado permite,en los pacientes con obesidad mórbida candidatos a cirugía bariátrica,detectar aquellos sin fibrosis avanzada, pero no permite predeciraquellos que pueden tener una fibrosis avanzada(AU)

Objective: to evaluate the usefulness of a non-invasive clinicalscore to predict liver fibrosis in the steatosis associated with morbidobesity.Patients and methods: we included 88 patients, who underwentbariatric surgery in the Sanitary Area of León, Spain, andwho showed a liver biopsy with steatosis greater than 5%. This isa retrospective study in which the rate of fibrosis is calculated fromtests performed during the preoperative period, and is then comparedto data from intraoperative hepatic biopsies. The analysispopulation was grouped according to the presence of advanced fibrosisin the liver biopsy (grade 3-4) or its absence (grade 0-2).The cutoff used for diagnosing advanced fibrosis was 0.676 (highcutoff point), and the cutoff point to exclude advanced fibrosis was-1.455 (low cutoff).Results: the prevalence of advanced fibrosis in the histologicalsamples was 5.5%, and 65.9% of patients had no fibrosis. Thecutoff for a low negative predictive value was 100%, and sensitivitywas 100%. The cutoff point for a high positive predictive valuewas 1.7%, and specificity was 31.3%.Conclusions: this scoring system for morbidly obese patientseligible for bariatric surgery allows to identify those without advancedfibrosis, but cannot predict who may have advanced fibrosis(AU)

[Integrated treatment of cleft lip and palate. Organization of a treatment team]. / Tratamiento integral de las fisuras labio palatinas. Organización de un equipo de tratamiento.

OBJECTIVE: Collect the team experience in the treatment of children with cleft lip and palate, indicating the evolution of the team composition, advantages and improvement aspects, trying to transmit the need of team treatment. METHOD: The Bilbao cleft palate team was created in 1983, since then a cleft palate clinic, a parents group and a unit of velopharyngeal function has been developed. At present the team is composed by: pediatric reconstructor surgeon, speech therapist, orthodontist, dentist, pediatrician, ENT, maxillofacial surgeon, dismorphologyst, geneticist, nursing. RESULTS: One of the achievements has been the data unification, obtaining speech cephalometrics, photographic dental casts and video images with prospective view. At this time 403 cleft lip and palate children have been intervened, being essential the transdisciplinar team approach between surgeon, speech therapist and orthodontist. The importance of the team coordinator is pointed. The results of an audit of the two stage cleft palate closure in complete unilateral cleft lip and palate have obligated us to vary our surgical policy. The unresolved aspects are the lack of multidisciplinary team recognition at official level and the non existence of orthodontist in staff, without cost coverage of this treatment by public health system. CONCLUSIONS: In our experience the team treatment of cleft lip and palate has resulted in improvement of the clinic results, treatment protocols and training.